Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edotecarin in Anthracycline- and Taxane-Refractory or Chemoresistant Metastatic Breast Cancer
NCT00070031Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2003
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edotecarin in breast cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 2003; status: completed.
02
Drugs
edotecarin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00070031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070031.